Clinical and radiological features of patients with macroprolactinaemia

Clinical Endocrinology

Volumn 59, Issue 3, 2003, Pages 339-346

  Strachan, Mark W J ^a   Teoh, Wei Leng ^b   Don Wauchope, Andrew C ^b   Seth, John ^b   Stoddart, Mary ^b   Beckett, Geoffrey J ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMANS; HYPERPROLACTINEMIA; IMPOTENCE; INFERTILITY, FEMALE; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0042326324     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01852.x     Document Type: Article

References (28)

1. Bjøro, T., Mørkrid, L., Wergeland, R., Turter, A., Kvistborg, A., Sand, T. & Torjesen, P. (1995) Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigation, 55, 139-147.
2. Cavaco, B., Leite, V., Santos, M.A., Arranhado, E. & Sobrinho, L.G. (1995) Some forms of big, big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. Journal of Clinical Endocrinology and Metabolism, 80, 2342-2346.
3. Fahie-Wilson, M.N. (1999) Polyethylene glycol precipitation as a screening method for macroprolactinemia. Clinical Chemistry, 45, 436-437.
4. Fahie-Wilson, M.N. (2000) Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clinical Chemistry, 46, 2022-2023.
5. Fahie-Wilson, M. & Soule, S. (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Annals of Clinical Biochemistry, 34, 252-258.
6. Fahie-Wilson, M., Brunsden, P., Surrey, J. & Everitt, A. (2000) Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clinical Chemistry, 46, 1993-1995.
7. Fraser, I.S., Lun, Z.G., Zhou, J.P., Herington, A.C., McCarron, G., Caterson, I., Tan, K. & Markham, R. (1989) Detailed assessment of big prolactin in women with hyperprolactinemia and normal ovarian function. Journal of Clinical Endocrinology and Metabolism, 69, 585-592.
8. Gilson, G., Schmit, P., Thix, J., Hoffman, J.-P. & Humbel, R.-L. (2001) Prolactin results for samples containing macroprolactin are method and sample dependent. Clinical Chemistry, 47, 331-333.
9. Hall, W.A., Luciano, M.G., Doppman, J.L., Patronas, N.J. & Oldfield, E.H. (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Annals of. International Medicine, 120, 817-820.
10. Hattori, N. (1996) The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. Journal of Clinical Endocrinology and Metabolism, 81, 586-590.
11. Hattori, N. & Inagaki, C. (1997) Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism, 82, 3107-3110.
12. Hattori, N., Ishihara, T., Ikekubo, K., Moridera, K., Hino, M. & Kurahachi, H. (1992) Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 75, 1226-1229.
13. Hauache, O.M., Rocha, A.J., Maia, A.C.M., MacIel, R.M.B. & Vieira, J.G.H. (2002) Screening for macroprolactinaemia and pituitary imaging studies. Clinical Endocrinology, 57, 327-331.
14. Jackson, R.D., Wortsman, J. & Malarkey, W.B. (1985a) Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. Journal of Clinical Endocrinology and Metabolism, 61, 258-264.
15. Jackson, R.D., Wortsman, J. & Malarkey, W.B. (1985b) Macroprolactinemia presenting like a pituitary tumor. American Journal of Medicine, 78, 346-350.
16. John, R., McDowell, I.F.W., Scanlon, M.F. & Ellis, A.R. (2000) Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clinical Chemistry, 46, 884-885.
17. Leite, V., Cosby, H., Sobrinho, L.G., Fresnoza, A., Santos, M.A. & Friesen, H.G. (1992) Characterization of big, big prolactin in patients with hyperprolactinaemia. Clinical Endocrinology, 37, 365-372.
18. Leslie, H., Courtney, C.H., Bell, P.M., Hadden, D.R., McCance, D.R., Ellis, P.K., Sheridan, B. & Atkinson, A.B. (2001) Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism, 86, 2743-2746.
19. Miyai, K., Ichihara, K., Kondo, K. & Mori, S. (1986) Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin. Clinical Endocrinology, 25, 549-554.
20. Olukoga, A.O. & Kane, J.W. (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clinical Endocrinology, 51, 119-126.
21. Pinto, L., Evans, M., Hanna, F. & Scanlon, M. (2002) The use of the domperidone test in differentiating macroprolactinaemia from true hyperprolactinaemia. Presented at the Annual Meeting of the British Endocrine Societies, 2002: http://www.endocrine-abstracts.org/ea/0003/ea0003p57.htm.
22. Schlechte, J.A. (2002) The macroprolactin problem. Journal of Clinical Endocrinology and Metabolism, 87, 5408-5409.
23. Smith, T.P., Suliman, A.M., Fahie-Wilson, M.N. & McKenna, T.J. (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. Journal of Clinical Endocrinology and Metabolism, 87, 5410-5415.
24. Vallette-Kasic, S., Morange-Ramos, I., Selim, A., Gunz, G., Morange, S., Enjalbert, A., Martin, P.-M., Jaquet, P. & Brue, T. (2002) Macroprolactinemia revisited: a study on 106 patients. Journal of Clinical Endocrinology and Metabolism, 87, 581-588.
25. Vieira, J.G.H., Tachibana, T.T., Obara, L.H. & MacIel, R.M.B. (1998) Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clinical Chemistry, 44, 1758-1759.
26. Whittaker, P.G., Wilcox, T. & Lind, T. (1981) Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin. Journal of Clinical Endocrinology and Metabolism, 53, 863-866.
27. Whitaker, M.D., Klee, G.G., Kao, P.C., Randall, R.V. & Heser, D.W. (1983) Demonstration of biological activity of prolactin molecular weight variants in human sera. Journal of Clinical Endocrinology and Metabolism, 58, 826-830.
28. Wortsman, J., Carlson, H.E. & Malarkey, W.B. (1989) Macroprolactinemia as the cause of elevated serum prolactin in men. American Journal of Medicine, 86, 704-706.